MoneyWorks4Me

Abbott India reports Profit after tax of Rs 1807.30 Mln, in the September 2020 quarter

11 Nov 2020 Evaluate
Revenue showed a marginal decline at Rs. 10548.50 millions. For the quarter ended September 2020, as compared to corresponding quarter of last year.Profit for the quarter ended September 2020 increased merely by1.35% to Rs. 1807.30  millions from Rs. 1783.30 millions.The company reported a good operating profit of 2627.70 millions compared to 2330.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 10548.50 10548.00 0.00 21191.20 20536.90 3.19 40931.40 36786.00 11.27
Other Income 220.60 289.00 -23.67 496.90 585.00 -15.06 1143.90 1132.90 0.97
PBIDT 2627.70 2330.30 12.76 5238.20 4368.10 19.92 8708.30 7180.20 21.28
Interest 47.90 18.20 163.19 92.40 38.50 140.00 85.30 22.50 279.11
PBDT 2579.80 2312.10 11.58 5145.80 4329.60 18.85 8623.00 7157.70 20.47
Depreciation 142.90 149.50 -4.41 283.90 297.50 -4.57 596.10 169.20 252.30
PBT 2436.90 2162.60 12.68 4861.90 4032.10 20.58 8026.90 6988.50 14.86
TAX 629.60 379.30 65.99 1251.10 1079.40 15.91 2097.60 2485.20 -15.60
Deferred Tax -19.50 19.70 -198.98 -34.00 11.80 -388.14 14.70 26.40 -44.32
PAT 1807.30 1783.30 1.35 3610.80 2952.70 22.29 5929.30 4503.30 31.67
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 24.91 22.09 12.76 24.72 21.27 16.22 21.28 19.52 9.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..